Pacific Biosciences of California (PACB) is a Healthcare · Medical Devices company listed on NASDAQ. Price $1.37 (-0.72%), Market cap $0.36B, 52-week low–high $0.91 ~ $2.67.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on
Financial statements, price targets, institutional (13F) holdings and related news for Pacific Biosciences of California are updated in real time on BlackAll Trade.
Pacific Biosciences of California trades at $1.37 (-0.72%). Real-time quotes and charts are available on BlackAll Trade.
Pacific Biosciences of California has a market cap of about $0.36B.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products,